Esmatjes E, Fernandez M R, Halperin I, Camps J, Gaya J, Arroyo V, Rivera F, Figuerola D
J Clin Endocrinol Metab. 1985 Jun;60(6):1231-6. doi: 10.1210/jcem-60-6-1231.
To determine if renal functional alterations in diabetes mellitus could be related to disturbances of vasoactive systems, renal plasma flow (RPF), glomerular filtration rate (GFR), PRA (basal and stimulated), plasma catecholamine levels, and urinary excretion of prostaglandin E2 (PGE2), 6-keto-PGF1 alpha, and kallikrein were determined in 21 patients with insulin-dependent diabetes mellitus (IDDM) of short duration and 15 normal subjects. In 7 additional patients with IDDM and in 4 normal subjects, the effect of lysine acetylsalicylate (LAS; 450 mg, iv) on GFR and RPF was studied. Patients with IDDM had higher RPF and GFR than normal subjects. Plasma norepinephrine and basal and stimulated PRA were significantly lower in IDDM than in the control group [161 +/- 82 (+/- SD) vs. 243 +/- 114 pg/ml, 0.19 +/- 0.20 vs. 1.15 +/- 0.33 ng/ml X h, and 0.93 +/- 0.82 vs. 2.8 +/- 1.73 ng/ml X h, respectively). No significant differences were found in the urinary excretion of PGE2, 6-keto-PGF1 alpha, and kallikrein in the two groups. LAS administration significantly reduced RPF (from 641 +/- 72 to 535 +/- 38 ml/min X 1.73 m2) and GFR (from 168 +/- 25 to 150 +/- 18 ml/min X 1.73 m2) in patients with IDDM, but not in normal subjects. In IDDM patients, there was a close direct correlation between the percent decrease in RPF and GFR induced by LAS and the baseline values of these parameters. The results suggest that in IDDM, there may be an imbalance between the degree of activation of the renin-angiotensin and sympathetic nervous systems and the renal production of PGs. The observation that LAS administration reduced RPF and GFR in these patients suggests that renal PGs are involved in the renal hyperperfusion of IDDM.
为了确定糖尿病患者的肾功能改变是否与血管活性系统紊乱有关,我们测定了21例病程较短的胰岛素依赖型糖尿病(IDDM)患者及15名正常受试者的肾血浆流量(RPF)、肾小球滤过率(GFR)、肾素活性(基础及刺激后)、血浆儿茶酚胺水平以及前列腺素E2(PGE2)、6-酮-前列腺素F1α和激肽释放酶的尿排泄量。另外,我们还研究了7例IDDM患者及4名正常受试者静脉注射赖氨酸乙酰水杨酸(LAS;450mg)对GFR和RPF的影响。IDDM患者的RPF和GFR高于正常受试者。IDDM患者血浆去甲肾上腺素以及基础和刺激后的肾素活性显著低于对照组[分别为161±82(±标准差)对243±114pg/ml、0.19±0.20对1.15±0.33ng/ml·h以及0.93±0.82对2.8±1.73ng/ml·h]。两组间PGE2、6-酮-前列腺素F1α和激肽释放酶的尿排泄量无显著差异。静脉注射LAS可使IDDM患者的RPF(从641±72降至535±38ml/min·1.73m2)和GFR(从168±25降至150±18ml/min·1.73m2)显著降低,但对正常受试者无此影响。在IDDM患者中,LAS诱导的RPF和GFR降低百分比与这些参数的基线值之间存在密切的直接相关性。结果表明,在IDDM中,肾素-血管紧张素系统和交感神经系统的激活程度与肾脏前列腺素的产生之间可能存在失衡。LAS给药可降低这些患者的RPF和GFR这一观察结果提示,肾脏前列腺素参与了IDDM的肾脏高灌注。